Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors

Conditions

• HIV Infections

Interventions

• DRUG: Amprenavir

Sponsor

Glaxo Wellcome